-------
                                  DISCLAIMER

    This report  1s  an external draft  for  review purposes only  and  does not
constitute  Agency  policy.   Mention of  trade names  or  commercial  products
does not constitute endorsement or recommendation for use.
                                      11

-------
                                   PREFACE
    Health and  Environmental  Effects  Documents  (HEEOs) are prepared  for  the
Office of Solid  Waste  and Emergency Response (OSWER).  This  document  series
Is Intended to support listings under  the  Resource  Conservation  and  Recovery
Act  (RCRA) as  well as to  provide  health-related  limits and  goals for  emer-
gency and  remedial actions under  the Comprehensive  Environmental Response,
Compensation  and  Liability  Act  (CERCLA).   Both   published  literature  and
Information obtained from  Agency Program Office files are evaluated  as  they
pertain to potential human health,  aquatic life and environmental  effects  of
hazardous waste  constituents.   The  literature searched for In this  document
and  the  dates  searched  are  Included In  "Appendix: Literature  Searched."
Literature search  material  Is  current up  to  8  months previous  to the  final
draft date  listed  on  the front cover.   Final draft  document  dates  (front
cover) reflect the date the document Is sent  to  the  Program Officer (OSWER).

    Several  quantitative  estimates are  presented  provided   sufficient  data
are available.   For systemic toxicants,  these Include  Reference  doses  (RfDs)
for  chronic  and  subchronlc  exposures  for   both   the  Inhalation  and  oral
exposures.  The  subchronlc or  partial  lifetime  RfD,  1s  an  estimate of  an
exposure  level   that would not  be expected  to cause  adverse  effects  when
exposure occurs  during a  limited time  Interval,  for example, one that  does
not constitute a significant portion of  the Hfespan.  This type of  exposure
estimate has  not been extensively  used, or  rigorously  defined  as  previous
risk  assessment   efforts   have  focused  primarily  on   lifetime  exposure
scenarios.  Animal data  used  for  subchronlc  estimates  generally   reflect
exposure durations  of  30-90  days.   The general  methodology   for  estimating
subchronlc RfDs  Is  the same as  traditionally  employed  for  chronic  estimates,
except that  subchronlc  data are utilized  when  available.

    In  the  case  of   suspected  carcinogens,  RfDs  are  not   estimated.   A
carcinogenic  potency factor,  or q-|*  (U.S. EPA,  1980), 1s provided  Instead.
These potency  estimates are  derived for both oral  and Inhalation exposures
where possible.  In addition,  unit  risk  estimates for  air  and drinking  water
are presented  based on  Inhalation and  oral  data,  respectively.

    Reportable quantities  (RQs) based  on both chronic toxldty  and  cardno-
genlclty are derived.  The  RQ  Is  used to determine  the quantity of  a  hazar-
dous substance for  which  notification  1s required  1n  the  event  of a  release
as specified under  the CERCLA.  These  two  RQs  (chronic  toxldty  and  cardno-
genlclty) represent two of  six  scores developed (the remaining  four  reflect
tgnltabllUy,   reactivity,  aquatic  toxldty,  and  acute mammalian  toxldty).
Chemical-specific RQs reflect  the lowest of these six  primary criteria.   The
methodology for  chronic  toxldty and  cancer-based  RQs are  defined   1n  U.S.
EPA, 1984 and  1986a, respectively.
                                      111

-------
                               EXECUTIVE  SUMMARY

    Furan  1s  a colorless,  low-boiling  and highly  flammable  liquid at  room
temperature,  with  a  strong  ethereal  odor   (McKllUp  and  Sherman,  1980).
Unless  stabilized,   1t  will  react  slowly with  air  to  form  an  unstable,
explosion-prone peroxide  {Ounlop,  1966).   It Is mlsdble  with most  common
organic solvents  (McKllUp and Sherman,  1980) and the solubility  1n  water  1s
10  g/SL  at   25°C  (Dunlop,   1966).    Furan  Is  produced  commercially   by
decarbonylatlon of  furfural  (McKllUp  and  Sherman, 1980).   QO  Chemicals,
Inc., Memphis, TN,  1s  the only domestic manufacturer of  this compound  (SRI,
1986;  USITC,  1986).   Production  volume  data could  not  be  located 1n the
available  literature  as  cited  1n  Appendix  A.   Furan  Is   used  as   an
Intermediate  In   the  production  of  other  Industrial  chemicals,  especially
pyrrole,   tetrahydrofuran   and  thlophene;   for   use  as  Pharmaceuticals,
herbicides  and various  polymers (Hawley,  1981; McKllUp  and  Sherman,  1980).
    If  released   to the  atmosphere,  furan  Is  expected  to  exist  almost
entirely  1n  the   vapor   phase.    Reaction with  photochemlcally   generated
hydroxyl radicals  Is  predicted to  be the primary  removal  mechanism  during
daylight  (half-life,   2-6 hours)  and   reaction  with  nitrate   radicals   Is
predicted to be the primary  removal  mechanism (half-life, -1/2 hour)  during
nighttime.   Removal from  the  atmosphere by reaction  with ozone or  physical
processes 1s expected to  be  relatively Insignificant.   If furan Is  released
to  water,   volatilization  Is  expected  to  be  an   Important,   If  not  the
dominant,  removal  mechanism.   The  volatilization  half-life  of furan  1n  a
typical river  1 m deep,  flowing 1 m/sec,  with  a wind  speed  of 3 m/sec was
estimated  to  be   2.5  hours   (see  Section  2.2.4.).   Chemical hydrolysis,
bloaccumulatlon 1n  aquatic  organisms  and  physical   adsorption  to  suspended
solid  or  sediments are  not  expected to  be  Important fate  processes.    If

                                      1v

-------
released  to  moist soil,  furan  may be  susceptible  to rapid  volatilization.
In the absence of significant blotlc  or  abiotic  processes,  residual  furan 1n
moist  soils   Is   susceptible  to  significant  leaching   to  groundwater.   If
released to dry soil, furan may  volatilize rapidly.
    The  most  probable  route  of human  exposure  to  furan  1s by  Inhalation.
Infants may be exposed  to  this  compound  by  Ingestlon  of  mother's  milk,  since
furan  had  been  detected 1n 1 of  12  samples of mother's milk  (PelUzzaM  et
al.,  1982).   Furan  has  also  been  Identified as  a volatile  component  of
roasted  filberts  (K1nl1n  et  al.,  1972).   Furan  has been  Identified  as  a
gas-phase  component  of cigarette  smoke  (Sakuma  et  al.,  1975),  wood  smoke
(Klelndlenst   et  al.,  1986),  exhaust gas  from delsel  and gasoline  engines
(Hampton et  al.,  1982) and volatile  emissions from  sorb  trees (Isldorov  et
al., 1985).   Furan was  detected 1n the expired air of two out  of  three male
smokers  and  four out  of  five  male  nonsmokers from  Brooks  Air Force  Base,
TX.  The rate of  furan expiration  ranged   between 0.25-98  for smokers  and
0.33-28  yg/hr for  nonsmokers  (Conkle  et  al.,   1975).   This  compound  has
also been  detected  In the expired air  from male and female  nonsmokers  from
Chicago,  IL  (Krotoszynskl  et al.,  1979).   This  compound  has  been  qualita-
tively  Identified 1n the  Niagara River  and two  creeks   1n the  Niagara  River
watershed (Elder  et  al., 1981; Great  Lakes Water  Quality  Board.  1983).
    Little Information was available  concerning toxldty of  furan  to  aquatic
biota.    Velth  et  al.  (1983)   reported  a  96-hour  LC5Q  of  61   mg/8,  for
fathead  minnows.  Call  et al.  (1985) calculated  an HATC of  10.0 mg/8,  based
on  a  NOEC  of  8.27  mg/l  and  a   LOEC  of  12.2  mg/4.  from  a   31-33  day
continuous flow bloassays  with early  life stages  of  fathead minnows.
    Information regarding  the  pharmacoklhetlcs  of  furan  was  limited.   The
available data Indicate that  furan 1s absorbed extensively by the  Inhalation
route  (Egle and Gochberg, 1979)  and was  distributed to  the lungs,  kidney and

-------
liver  following IntraperHoneal  Injection  (Gammal  et a!.,  1984; Wiley  et
al., 1984).  Metabolic  activation  may be required for  furan  Induced  toxlclty
(Hasuda et al., 1984).
    Dose-related toxic  hepatitis  was  reported  In both  sexes  of  F-344  rats
and  B6C3F1  mice when  furan was  administered  by gavage  for  13 weeks  (SRI,
1982a,b).  The  liver lesions were  considered  minimal  1n low-dose rats  and
did  not  occur  In  the  two  lowest  dose  groups  of  male and  female  mice.
High-dose male  and  female rats  and  high-dose  male mice  had  reduced  body
weight  gains.   Dose-related Increase  In  liver  weight was  reported  1n  all
treated rats except  low-dose females and 1n male and  female mice  at  the two
highest dose levels.
    Pertinent data  regarding  the cardnogenlclty,  teratogenlclty or  other
reproductive effects of  furan  could  not be located  1n  the available  litera-
ture as  cited  1n  Appendix A.   Furan  was  reported  to  be nonmutagenlc  when
tested  In the  presence and absence  of S-9 In  assays with Salmonella typhl-
murlum and Euglena gracllls (Hortelmans et al.,  1986;  EbMnge et al., 1979).
Furan was clastogenlc  to  Chinese hamster  ovary  cells  when  cultured In  the
presence of  S-9 (Stlch et al.,  1981).
  .  A subchronlc RfD for oral exposure  of  1 mg/day was  based on  the NOAEL  of
2 mg/kg  for  mice  In the  13-week  gavage study  (SRI,  1982b).  Application  of
an additional  uncertainty  factor  yielded  an  RfD of  0.1  mg/day for  chronic
oral exposure.  An RQ of 100 for  furan  was  based on  the occurrence of severe
liver lesions In male mice In the  same study (SRI, 1982b).
                                      v1

-------
                              TABLE  OF  CONTENTS
1.  INTRODUCTION	    1

    1.1.   STRUCTURE AND CAS NUMBER	    1
    1.2.   PHYSICAL AND CHEMICAL PROPERTIES 	    1
    1.3.   PRODUCTION DATA	    2
    1.4.   USE DATA	    2
    1.5.   SUMMARY	    2

2.  ENVIRONMENTAL FATE AND TRANSPORT	    4

    2.1.   AIR	    4

           2.1.1.   Reaction with Hydroxyl Radicals 	    4
           2.1.2.   Reaction with Ozone 	    4
           2.1.3.   Reaction with Nitrate Radicals	    4
           2.1.4.   Physical Removal Processes	    4

    2.2.   WATER	    5

           2.2.1.   Hydrolysis	    5
           2.2.2.   B1oaccumulat1on 	    5
           2.2.3.   Adsorption	    5
           2.2.4.   Volatilization	    6
           2.2.5.   B1odegradat1on	    6

    2.3.   SOIL	    6

           2.3.1.   Leaching	    6
           2.3.2.   Volatilization	    6

    2.4.   SUMMARY	    7

3.  EXPOSURE	    8

    3.1.   WATER	    8
    3.2.   FOOD	    8
    3.3.   INHALATION	    8
    3.4.   DERMAL	    9
    3.5.   SUMMARY	    9

4.  AQUATIC TOXICITY	   11

    4.1.   ACUTE TOXICITY	   11
    4.2.   CHRONIC EFFECTS	   11
    4.3.   PLANT EFFECTS	   11
    4.4.   SUMMARY	   11

-------
                          TABLE  OF  CONTENTS  (cont.)
    PHARMACOKINETCS
    5.1.   ABSORPTION ........................    12
    5.2.   DISTRIBUTION .......................    12
    5.3.   METABOLISM ........................    13
    5.4.   EXCRETION .........................    13
    5.5.   SUMMARY ..... .  ....................    13

6.  EFFECTS .............................    15

    6.1.   SYSTEMIC TOXICITY .............  ........    15

           6.1.1.   Inhalation Exposures ...............    15
           6.1.2.   Oral Exposures ..................    15
           6.1.3.   Other  Relevant Information ............    16

    6.2.   CARCINOGENICITY ......................    16

           6.2.1.   Inhalation and Oral  ...............    16
           6.2.2.   Other  Relevant Information ............    17

    6.3.   MUTAGENICITY .......................    17
    6.4.   TERATOGENICITY  ......................    17
    6.5.   OTHER REPRODUCTIVE  EFFECTS ................    17
    6.6.   SUMMARY ..........................    17

7.  EXISTING GUIDELINES AND STANDARDS ................    19

    7.1.   HUMAN ...........................    19
    7.2.   AQUATIC ..........................    19

8.  RISK ASSESSMENT .........................    20

    8.1.   CARCINOGENICITY .............  .  .  .......    20

           8.1.1.   Weight of  Evidence ................    20
           8.1.2.   Quantitative Risk Estimates  ...........    20

    8.2.   SYSTEMIC TOXICITY .....................    20

           8.2.1.   Inhalation Exposure  ...............    20
           8.2.2.   Oral Exposure ..................    20

9.  REPORTABLE QUANTITIES  ......................    23

    9.1.   BASED ON SYSTEMIC TOXICITY .  .  ..............    23
    9.2.   BASED ON CARCINOGENICITY .................    23

-------
                           TABLE  OF  CONTENTS  (cont.)
10.  REFERENCES.
APPENDIX A: LITERATURE SEARCHED	   35
APPENDIX B: SUMMARY TABLE FOR FURAN	   38
                                      1x

-------
                             LIST OF  ABBREVIATIONS

BCF                     Bloconcentratlon factor
CAS                     Chemical Abstract Service
CS                      Composite score
Koc                     Soil sorptlon coefficient standardized
                        with respect to organic carbon
Kow                     Octanol/water partition coefficient
LOEC                    Lowest-observed-effect concentration
MATC                    Maximum acceptable toxicant concentration
MED                     Minimum effective dose
NOAEL                   No-observed-adverse-effect level
NOEC                    No-observed-effect concentration
ppb                     Parts per billion
RfD                     Reference dose
RQ                      Reportable quantity
RV(j                     Dose-rating value
RVe                     Effect-rating value

-------
                               1.  INTRODUCTION
1.1.   STRUCTURE AND CAS NUMBER
    Furan  1s  also  known  as  furfuran,  oxole,  dlvlnylene  oxide and  tetrole
(Wlndholz,  1983).   The structure,  molecular  weight,  empirical formula  and
CAS Registry number for this compound are as follows:
Molecular weight:  68.08
Empirical formula:  C.H.O
CAS Registry number:  110-00-9
1.2.   PHYSICAL AND CHEMICAL PROPERTIES
    Furan  1s  a   flammable,  colorless  liquid  at  room  temperature  with  a
strong,  ethereal  odor  {McKlllIp and  Sherman,  1980).   Although It will  turn
brown  while  standing In air,  the  addition of  a  small  amount of water  will
retard  color change  (Hawley,   1981).   Unless  stabilized,  furan  will  react
slowly  with  air   to  form  an  unstable,   explosion-prone  peroxide  (Dunlop,
1966).   Butylated hydroxytoluene  (BHT)  1s  added  to  Inhibit this  reaction
(Verschueren,  1983).   Furan Is  mlsdble with  most common organic  solvents
Including  ethyl   acetate,   methanol,   ethanol,  acetone,  toluene,  petroleum
ether  and  chloroform {McKHHp and Sherman, 1980;  Dunlop,  1966).   Pertinent
physical properties are as  follows:
    Melting point, °C:             -85.6               R1dd1ck  et al.,  1986
    Boiling point, °C:             31.4                Rlddlck  et al.,  1986
    Vapor pressure at 25°C:        600 mm Hg           Boubllk  et al.,  1984
    Water solubility at 25°C:     1.01x10*  mg/a       Valvanl  et al.,  1981
    Log Kow:                      1.34                Hansch and Leo,  1985
    Specific gravity, 20/4°C:     0.9378              Rlddlck  et al.,  1986
                       20
    Refractive Index, njju:         1.4214              Rlddlck  et al.,  1986

0067d                               -1-                              10/02/87

-------
    Flashpoint, °C:               -36 (closed cup)     R1dd1ck  et  al.,  1986

    Furan  undergoes   substitution  and  addition  reactions  under  controlled
conditions  (McK1ll1p  and  Sherman,  1980).   Furan  1s  hydrolyzed by  aqueous
adds, and this reaction 1s accompanied  by res1n1f1cat1on  (U.S. EPA, 1986b).
1.3.   PRODUCTION DATA
    Furan  1s  produced commercially  by decarbonylatlon of furfural  (HcKlllIp
and Sherman,  1980).   QO Chemicals,  Inc.,  Memphis, TN,  1s the only domestic
manufacturer  of  this  compound (SRI,  1986;  USITC,  1986).   Production volume
data could not be located In the  available literature  as cited  1n Appendix A.
1.4.   USE DATA
    Furan  1s  used  as  an Intermediate 1n  the production of other  Industrial
chemicals, especially pyrrole, tetrahydrofuran  and thlophene  (Hawley, 1981;
McK1ll1p  and  Sherman,  1980).  It  Is also used as  an Intermediate  1n  the
production of  Pharmaceuticals, herbicides,  stabilizers  and various polymers
(McKllUp and Sherman, 1980).
1.5.   SUMMARY
    Furan  Is   a  colorless, flammable  liquid  at   room  temperature,  with  a
strong ethereal  odor  (McKHlIp and Sherman,  1980).   Unless  stabilized with
BHT,  1t  will  react   slowly with air to  form an  unstable,  explosion-prone
peroxide  (Duniop,  1966).   It  1s  mlsdble with most  common  organic solvents
and 1s  slightly soluble  1n water  (McKllUp and   Sherman, 1980).   Furan 1s
produced commercially by decarbonylatlon  of furfural  (McKllUp and Sherman,
1980).  QO  Chemicals,  Inc.,  Memphis,  TN,  1s  the  only domestic  manufacturer
of this compound (SRI. 1986; USITC, 1986).  Production volume data could not
be  located  In  the available  literature  as  cited  1n  Appendix A.   Furan Is
used  as  an Intermediate  In the production  of other  Industrial chemicals;
0067d                               -2-                              10/02/87

-------
especially   pyrrole,   tetrahydrofuran    and    thlophene;   for    use    as
Pharmaceuticals, herbicides and various polymers  (Hawley,  1981;  McKlllIp  and
Sherman, 1980).
0067d                               -3-                              09/25/87

-------
                     2.  ENVIRONMENTAL FATE AND TRANSPORT

    Pertinent data  regarding the environmental  fate  and transport of  furan
are  limited.   When possible,  Information concerning  fate  and transport  of
this  compound  were   derived  from   physical   property   data   or   molecular
structure.
2.1.   AIR
    Because  of  Us  relatively  high  vapor pressure  of  600  mm  Hg at  25°C
(Boubllk  et  al.,  1984),  furan  Is  expected to  exist  almost entirely In  the
vapor phase In the atmosphere (Elsenrelch et al.,  1981).
2.1.1.   Reaction wHh Hydroxyl  Radicals.  The half-life  for the  reaction
of  furan  with  photochemically  generated hydroxyl  radicals  at  22°C has  been
calculated  to be  6.0  and  2.3  hours,  using  experimentally  derived   rate
constants   of   4.0X10"11   and    1.05xlO~10    cm3/molecule-sec   (Atkinson,
1985; Lee and Tang, 1982), respectively, and an average  atmospheric  hydroxyl
radical concentration of 8.0xl05  molecules/cm3  (U.S. EPA,  1987)
2.1.2.   Reaction with  Ozone.  The  half-life  for  furan  reaction  with  ozone
In  the  atmosphere was estimated  to be  3.3  days, using an  experimentally
derived  reaction  rate   constant  of  2.4xlO~18   cm3/molecule-sec  at   room
temperature  (Atkinson  et  al.,  1985)  and average ambient  ozone concentration
of lxlO~12 molecules/cm3 (U.S.  EPA,  1987).
2.1.3.   Reaction with  Nitrate  Radicals.  The half-life for  the  nighttime
reaction  of  furan  with nitrate  radicals (nitrate radicals  are unstable  to
sunlight)  In the  atmosphere  was  calculated  to  be   34  minutes,  using  an
experimentally determined reaction   rate  constant  of  1.4xlO~12  cmVmole-
cule-sec at  room temperature and an  average  ambient nitrate radical concen-
tration  of  2.4x10"   molecules/cm3   during  nighttime  hours   (Atkinson   et


0067d                               -4-                              09/25/87

-------
al., 1985).   By  analogy to alkenes  and  dlalkenes, nitrate  radical  reaction
with furan  Is  expected to proceed  Initially  by addition of the  NO-  radical
                                                                    0
to  the  oleflnlc  double bonds,  followed  by rapid  addition  of  0? to  yield  a
peroxy  radical.   Reaction  of  the  peroxy radical  with NO-  can then  yield
the  thermally  unstable peroxynltrates.   Although the  ultimate  fate of  the
peroxy  radical  1s  not  known,  H  1s   likely  that  ring  cleavage  would
eventually  occur,  resulting  In such  species as  CHOCH=CHOCHO  (Atkinson  et
al., 1985).
2.1.4.    Physical  Removal  Processes.   Reaction  of   furan   with   hydroxyl
radicals  or  nitrate  radicals  1s  expected to  HmU  the  Importance of  wet
deposition  as  an   atmospheric   removal  process.   Furthermore,  most  furan
removed by wet deposition Is  likely  to reenter  the atmosphere  by volatiliza-
tion (Section 2.2.4.).
2.2.   WATER
2.2.1.    Hydrolysis.   Based  on   the  molecular structure,  furan  1s  expected
to be resistant  to  chemical hydrolysis under  environmental  conditions (Lyman
et al., 1982).
2.2.2.    Bloaccumulatlon.   BCFs  of  3.4-6.1 were  estimated  using a  log  K
of  1.34  (Hansch  and  Leo,  1985),  a water  solubllHy(S)   of  1.01x10* mg/i
at 25°C (Valvanl et al., 1981)  and  the following  linear regression  equations
(Lyman et al., 1982):
                        log BCF  = 0.76 log K   - 0.23                   (2-1)
                        log  BCF  = 2.791  - 0.564  log S                    (2-2)
These  BCFs  suggest   that  bloaccumulatlon  In aquatic  organisms  1s  not  a
significant environmental  fate process for  furan.
2.2.3.    Adsorption.   Estimated  KQC  values   of  27-128   (Section   2.3.1.)
suggest that physical  adsorption  of  furan  to  sediments and  suspended sol Ids
In water would not  be significant.

0067d                               -5-                               10/02/87

-------
2.2.4.   Volatilization.   Henry's  Law  constant  for  furan  was  estimated  to
be  5.3xlO~3 atm-mVmol  at  25°C  using  a vapor  pressure  of  600  mm Hg  at
25°C  (Boubllk  et  al.,   1984)  and  a  water  solubility of  l.OlxlO4  mg/8,  at
25°C  (Valvanl  et al.,  1981).   Based on  this  value of Henry's  Law constant
the half-life  for  furan volatilizing from a typical  river  1 m deep,  flowing
1 m/sec, with  a  wind speed of  3  m/sec  was estimated to be 2.5  hours,  using
the method  of  Lyman  et  al.  (1982).   Therefore,  volatilization  Is expected  to
be the primary transport process for furan In water.
2.2.5.   Blodegradatlon.   Pertinent  data regarding  the  blodegradatlon  of
furan 1n water could not be located  1n  the  available  literature as dted  In
Appendix A.
2.3.   SOIL
2.3.1.   Leaching.    K    values of  27-128 were  estimated  for   furan,  using
a  log K    value  of 1.34  (Hansch  and  Leo, 1985),  a water  solubility  of
1.01x10*  mg/l  at   25°C   and   the   following   linear   regression  equations
(Lyman et al.,  1982):
                         log KQC = -0.55 log  S + 3.64                   (2-3)
                        log KQC  =  0.544  log KQW  + 1.377                  (2-4)
These K     values  suggest   that  furan  would be highly mobile  In soil and
susceptible to significant  leaching In  the absence of  significant  blotlc  or
abiotic  degradation processes (Swann et  al.,  1983).
2.3.2.   Volatilization.  The  relatively  high  vapor pressure  of furan  (600
mm  Hg at  25°C)  (Boubllk  et  al.,  1984)  suggests   that  this  compound  would
volatilize  fairly rapidly  from  dry  soil  surfaces.   It  appears  that volatili-
zation of   furan  from moist  soil  surfaces  would   also be  rapid  since the
compound does  not  have  a tendency to adsorb to soil and  It was  predicted  to
volatilize rapidly from water (see Sections 2.2.4.  and 2.3.1.).
0067d                               -6-                              09/25/87

-------
2.4.   SUMMARY
    If  released  to  the   atmosphere,   furan  1s  expected  to  exist  almost
entirely  1n  the  vapor  phase.   Reaction  with  photochemlcally  generated
hydroxyl  radicals  1s predicted  to  be  the  primary  removal mechanism  during
daylight  (half-life,  2-6  hours)   and  reaction  with  nitrate  radicals  Is
predicted to be  the primary removal mechanism (half-life,  -1/2  hour)  during
nighttime.  Removal  from  the atmosphere by  reaction  with  ozone  or  physical
processes 1s expected  to  be relatively Insignificant.  If  furan  1s  released
to  water,  volatilization  1s   expected to  be  an   Important,  1f  not  the
dominant,  removal  mechanism.   The  volatilization  half-life  of  furan  1n  a
typical  river  1  m  deep, flowing 1  m/sec,  with a wind  speed  of  3 m/sec was
estimated  to  be  2.5   hours   (see  Section  2.2.4.).   Chemical  hydrolysis,
bloaccumulatlon  1n  aquatic organisms  and  physical  adsorption  to  suspended
solid  or sediments  are not  expected  to  be Important  fate  processes.   If
released  to  moist  soil,  furan  may  be  susceptible  to rapid  volatilization.
In the absence of significant blotlc  or abiotic  processes,  residual  furan In
moist  soils   Is  susceptible  to  significant  leaching  to  groundwater.   If
released to dry soil, furan may volatilize  rapidly.
0067d                               -7-                              09/25/87

-------
                                 3.  EXPOSURE

    The National Occupational Hazard Survey  (NOHS),  prepared  by NIOSH during
1972-1974,  estimates  that   6804   workers   may  be  exposed   to   furan   1n
occupational settings, annually (NIOSH, 1984).
3.1.   WATER
    Limited data are  available on  the  detection  of furan  1n  water  samples.
This compound has been qualitatively Identified 1n  Gill  Creek  and  Bloody  Run
Creek, part of  the  Niagara  River watershed  (Elder et al.,  1981),  and 1n  the
Niagara River  (Great  Lakes Water  Quality Board,  1983).   This compound  was
detected  1n aqueous  condensate  samples from low-Btu gasification  of  Rosebud
coal at a  concentration  of  7+4 ppb; however, It was not  detected  (detection
limit  0.1 ppb)  1n  groundwater  or  coal  steam water  before  in  situ coal
gasification,  product  water  samples  obtained  during  jji  situ coal  gasifi-
cation, Omega  9 retort  water from \n  situ  oil  shale  processing or  boiler
blowdown water from In situ oil  shale  processing (PelUzzarl et al.,  1979).
3.2.   FOOD
    Furan  can be  found  1n  a  great variety  of  food products  and  beverages,
especially  1n  heated  food  products,  contributing  to  the  flavor  of  these
foods (Stlch et al., 1981).   Furan  has  been  qualitatively  Identified  In 1  of
12  samples  of  mothers'  milk  obtained  from  women  from four different  urban
areas  (PelUzzarl  et al.,  1982).   This  compound was  also Identified as  a
volatile component  of roasted  filberts  (K1nl1n et  al.,  1972).
3.3.   INHALATION
    Furan  has been  Identified as  a gas-phase  component  of cigarette  smoke
(Sakuma et  al.,  1975),  wood  smoke (Klelndlenst  et  al.,  1986), exhaust  gas
from  dlesel   and  gasoline  engines  (Hampton  et  al.,  1982)   and  volatile
emissions   from  sorb  trees  (Isldorov  et al., 1985).   Furan was detected  1n

0067d                               -8-                              10/02/87

-------
the expired air  of  two out of three male  smokers  and four out of  five  male
nonsmokers  from  Brooks A1r  Force  Base, TX.   The  rate of  expiration  ranged
from  0.25-98  yg/hour  for   smokers  and   0.33-28   yg/hour  for   nonsmokers
(Conkle et al.,  1975).  This  compound,  also  Identified  In  the expired  air  of
male and  female  nonsmokers  from  Chicago,  IL, was found 1n  15 of  387 expired
air  samples   (mean   concentration   0.547   ng/i)  taken   from  54   subjects
(Krotoszynskl   et al.,  1979).  Since  furan Is  a  volatile  compound,  1t  Is
likely that workers  Involved In the use  or handling of this  compound would
be exposed by Inhalation.
3.4.   DERMAL
    Pertinent data regarding  exposure  to furan  by  dermal  contact  could  not
be located 1n the available literature  as  cited 1n  Appendix A.
3.5.   SUMMARY
    The most  probable  route  of  human  exposure to  furan  Is by  Inhalation.
Infants may be exposed  to this compound by  Ingestlon  of mother's  milk, since
1t  was  detected  1n  1  of  12 samples  of  mother's milk  (PelUzzarl et  al.,
1982).    Furan  has   been  Identified  as  a  volatile  component  of roasted
filberts   (Klnlln  et  al.,  1972),  and as a  gas-phase component of  cigarette
smoke (Sakuma et  al.,  1975),  wood  smoke (Klelndlenst et al.,  1986), exhaust
gas  from  delsel  and  gasoline engines  (Hampton et al.,  1982) and  volatile
emissions  from  sorb  trees  (Isldorov et al.,  1985).   Furan was  detected  In
the expired air  of two out  of three male  smokers  and four out of  five  male
nonsmokers  from  Brooks Air  Force  Base, TX.   The rate  of furan  expiration
ranged  between  0.25-98  for  smokers  and  0.33-28  yg/hour  for   nonsmokers
(Conkle et al.,  1975).  This  compound  has  also  been  detected  1n  the expired
air from  male  and female nonsmokers from  Chicago,  IL (Krotoszynskl et  al.,
1979).   This compound has been qualitatively Identified In  the  Niagara River

0067d                               -9-                              10/02/87

-------
and  two  creeks  In  the Niagara  River  watershed (Elder  et  al.,  1981;  Great
Lakes Water Quality Board, 1983).
0067d                               -10-                             10/02/87

-------
                             4.   AQUATIC TOXICITY
4.1.   ACUTE TOXICITY
    The  aquatic  toxldty  data   base  for  furan  1s  limited.   Velth  et  al.
(1983)   reported   a  96-hour   LC5Q  of   61   mg/9.   for   fathead  minnows,
Plmephales promelas. 1n  a continuous flow bloassay.
4.2.   CHRONIC EFFECTS
    The  only  Information concerning chronic  toxldty  of  furan was provided
by  Call  et al.  (1985)   who  conducted  continuous flow  bloassays  with  early
life  stages of  fathead  minnows  exposed  to  contaminants for 31-33 days.   In
this  study,  the  NOEC   was   8.27   mg/l.   The  LOEC  was   12.2 mg/l.   which
resulted 1n significant  reductions  1n  growth  1n  terms  of  length  and weight.
Based  on  these  results,  the  authors  estimated  an   MATC,  which was  the
geometric mean of NOEC and LOEC,  of  10.0 mg/9..
4.3.   PLANT EFFECTS
    Pertinent  data regarding effects of furan on aquatic plants could  not be
located 1n the available literature  as  cited  1n Appendix A.
4.4.   SUMMARY
    Little Information was available concerning  toxldty of furan  to aquatic
biota.   Velth  et   al.   (1983)   reported  a  96-hour  LC5Q  of  61 mg/l  for
fathead minnows.   Call  et al. (1985)  calculated an  MATC  of 10.0 mg/t  based
on  a  NOEC of 8.27  mg/l and  a  LOEC of  12.2  mg/t from a  31-33  day fathead
minnow early life stage  test.
0067d                               -11-                             10/02/87

-------
                             5.  PHARMACOKINETICS

    Pertinent  Information  regarding   the   pharmacoklnetlcs   of  furan  was
limited.
5.1.   ABSORPTION
    Egle and  Gochberg  (1979)  Investigated absorption  of  furan  vapor  by  the
respiratory  tracts  of  mongrel  dogs weighing  9-23  kg.   Total  respiratory
tract,  lower  tract  and  upper  tract (proximal  to the  tracheal  bifurcation)
retention was  measured 1n dogs  anesthetized with pentobarbltal  and  allowed
to  breath  spontaneously from a  resplrometer,  or artificially  ventilated  1n
the case of  upper  tract determinations.  Percent retention was  estimated  as
the  difference  between the  amount  of  material Inspired  and  expired  or
recovered at the end of  the trachea.  Total  tract retention  was estimated  at
90.8-95.3X   for    Inspired  concentrations   of   0.4-0.6   jig/ma   (400-600
mg/m3).  Lower  tract   retention  ranged  from  87.3-93.2X,  which  1s  Inversely
related to  ventilation rate.   Upper tract retention  ranged  from 85.4-89.9%,
and apparently Identical values  were obtained from one-way (furan-contalnlng
air moving  1n  one direction)  and  two-way (air  movement  1n  both directions)
experiments.  Retention varied Inversely  with ventilation rate,  which ranged
from 6-18 cycles/minute.
5.2.   DISTRIBUTION
    Furan was  distributed  to  the  lungs,  kidney and  liver of  mice  following
1ntraper1toneal  Injection.   Gamma! et  al.   (1984) and Wiley  et al.  (1984)
administered a  4.1 mmol/kg  (-279  mg/kg) dose of  furan In  sesame  oil  by
Intraperltoneal  Injection  to  young  adult male ICR  mice, and measured  the
concentration of  furan In the  lung, Hver  and kidney at 1,  2 and  5  hours
after  treatment.   Peak  levels   1n  the  lung  and  liver  of  -200 nmols/g  of

0067d                               -12-                             10/02/87

-------
tissue  (-14 yg/g  tissue)  were  observed  at  the  1-hour  sampling.   In  the
kidney, a  concentration  of -110  nmol/g (-7.5 v9/g)  at  1  hour  Increased  to
-500  nmol/g (-34  jig/g)  by  2 hours  after treatment.   Terminal  concentra-
tions  (5  hours)  1n liver and kidney  had  declined  to -50  nmol/g  (-3.4  jig/g)
and In lung, to -100 nmol/g (~7  pg/g).
5.3.   METABOLISM
    Studies specifically designed to  Identify metabolites  of  furan  could  not
be  located  1n  the  available  literature as cited  1n Appendix A.   Masuda  et
al.  (1984), however,  reported that  furan-1nduced nephrotoxlclty  1n mice  was
Increased when  mice were  pretreated  with  carbon  tetrachloHde, a  toxicant
that selectively destroys the metabolic function of  the  liver.   The Investi-
gators concluded that more  unmetabollzed furan was available  for  transforma-
tion  to  nephrotoxlc compound(s)  by the kidney.   Administration  of  dlethyl-
dlthlocarbamate  or carbon  dlsulflde,  known   Inhibitors   of  the  mlcrosomal
enzyme system  of  the  liver and  kidney, reduced  the  nephrotoxlclty of  furan
1n  untreated   or  carbon  tetrachloMde  treated  mice.    The  Investigators
hypothesized that  dlethyldlthlocarbamate and carbon  dlsulflde acted directly
on  the kidney  to  suppress  the metabolic  activation  of furan  to  nephrotoxlc
compound(s).
5.4.   EXCRETION
    Pertinent  data  regarding  the  excretion  of  furan  could not be located  In
the available  literature  as dted 1n Appendix  A.
5.5.   SUMMARY
    Information regarding  the pharmacoklnetlcs  of furan  was limited.   The
available data  Indicate  that furan 1s  absorbed extensively  by   the  Inhala-
tion  route  (Egle  and Gochberg,  1979)  and was  distributed  to  the  lungs,
0067d                               -13-                             10/02/87

-------
kidney and  liver  following  1ntraper1toneal  Injection  (Gamma! et al.,  1984;
Wiley et al.,  1984).  Metabolic  activation may be required  for  furan  Induced
toxlclty (Masuda et al., 1984).
0067d                               -14-                             10/02/87

-------
                                  6.   EFFECTS
6.1.   SYSTEMIC TOXICITY
6.1.1.   Inhalation Exposures.  Pertinent data  regarding  the subchronlc and
chronic  toxlclty  of furan  as  a result of  Inhalation  exposure could  not  be
located In the available literature as dted 1n Appendix A.
                         «      .
6.1.2.   Oral Exposures.
    6.1.2.1.   SUBCHRONIC — SRI   (1982a,b)   conducted   subchronlc   gavage
studies on  furan  and  used F-344 rats  and B6C3F1  mice  for 13 weeks  at doses
ranging from  0-60 mg/kg furan  In  corn oil,  5 days/week.   Groups of  10 male
and 10 female rats  and  10  female  mice received  doses of 60,  30,  15, 8, 4 and
0 mg/kg.   Groups  of 10  male  mice received doses  of  30,  15,  8,  4, 2  and  0
mg/kg.   Gross necropsy  was  performed on  all  animals  and  data  regarding
mortality,  body  weight, organ  weights, and  clinical   and  hlstopathologlcal
signs of  toxldty were  evaluated.  Complete hlstopathology was  performed  on
all rats  at the 60 and  30 mg/kg  levels, all  control  rats and  mice,  female
mice  at  the 60 mg/kg level and male  mice  at  the 30 mg/kg  level.   Clinical
signs of  toxldty were  mostly  confined to male  and  female rats and  female
mice  1n the high-dose (60  mg/kg)  group.  Mortality  occurred  1n  9/10 male and
4/10  female rats at the  high-dose  level.  High-dose male  and  female rats and
high-dose  (30  mg/kg)  male mice had  treatment-related  reduced rates of  body
weight gain.  In rats, a dose-related  Increase  In  liver size  was reported  In
all treated  groups of males and  1n all but  the  low-dose group  of  females.
Hlstopathologlcal   examination revealed a  dose-related   Increased  severity  In
liver lesions In  the rats, with mild  to minimal  lesions observed at 4 mg/kg,
the lowest  level   tested.   Liver  alterations  associated  with  administration
of  furan  Included  cytomegaly, degeneration, necrosis and  nodular hyperplasla
of  the   hepatocytes,  liholanglofIbrosls,   hyperplasla   of  the  bile  duct
epithelium  and  a   pigment  deposition  In Kupffer  cells.  Additional  lesions

0067d                               -15-                             10/02/87

-------
found  only  In  high-dose animals that were  considered  treatment  related were
atrophy of  the thymus  and gonads, renal  tubular  dilatation and  degeneration
and necrosis of the renal tubular epithelium.
    In  mice,   treatment-related  Increases 1n  IWer  weight were  reported  In
males  at  a dose  of ^>15  mg/kg  and In  females at doses  of >30  mg/kg.   The
hlstopathologlcal examination revealed  a  dose-related  toxic hepatitis at >15
mg/kg  1n  females  and  at >8 mg/kg  In males.   Liver lesions  were  not  found  In
male mice  receiving doses of <4 mg/kg  and  1n female mice receiving  doses  of
<8 mg/kg.   In  addition  to  the  hepatic  alterations  reported above  In  rats,
other  liver changes reported In mice were  focal  flbrosls,  focal  cytologlcal
alteration, focal necrosis and focal  supportive Inflammation.
    6.1.2.1.   CHRONIC -- Results  of   an    ongoing   2-year   NTP-sponsored
carcinogenic gavage bloassay In  rats  and mice  are  currently not  available
(NTP,  1987).   This study  may   provide  Information concerning   the  chronic
toxldty of furan.
6.1.3.   Other  Relevant  Information.   In  an  abstract  from a Russian Study,
values  of  4.2,  2.8   and   1.8   mg/l   were  reported   for  LC,.,  LC    and
LC1&,  respectively, In albino rats  (Stasenkova  and  Kochetkova,  1968).   The
length  of  exposure was  not  reported.    Sax   (1984)  reported  an  Inhalation
LC5Q  of 120 mg/m3  In  mice  for a  1-hour  exposure and an  1ntraper1toneal
LOcQ   of   5200  tig/kg   for   rats.   Egle   and   Gochberg   (1979)   reported
Intraperltoneal L05Q values of 5.2 mg/kg for rats and 7.0 mg/kg  for mice.
6.2.    CARCINOGENICITY
6.2.1.   Inhalation and Oral.  Pertinent  data regarding the carclnogenlclty
of furan  by  oral  or Inhalation  exposure  routes  could  not be located  1n the
available literature as  dted  1n Appendix A.   According to a recent  Manage-
ment Status Report  (NTP,  1987),  NTP  Is currently evaluating  hlstopathologl-
cal data from a chronic gavage study  with  rats and mice.

0067d                              -16-                             10/02/87

-------
6.2.2.   Other Relevant  Information.   Other  relevant Information  regarding
the cardnogenlclty  of  furan could not  be  located In the  available  litera-
ture as cited In Appendix A.
6.3.   MUTAGENICITY
    Mortelmans et  al.  (1986)  reported  negative  results  1n strains  TA100,
1535, 1537 and 98  of Salmonella  typhlmurlum when  tested  by plate Incorpora-
tion  at  doses  of  furan  ranging  from  33.3-3333.3  yg/plate,  both  1n  the
presence  and  absence of  S-9,  which  was purified  from   livers  of rats  and
hamsters  following   Aroclor   1254  pretreatment  and   contained  metabolic
activation system.   Ebrlnge  et al. (1979)  also  reported that furan  was  not
rnutagenlc when  tested  1n assays  with  Salmonella  typhlmurlum  and  Euqlena
gradHs.  When  furan  was added  to  Chinese  hamster ovary cell  cultures,
Stlch  et  al.  (1981)  reported   a  concentration-related  Increase  1n  the
Incidence of  chromatld  breaks  and exchanges  1n  dlplold  metaphase  cell  only
In  the  presence  of metabolic activation.  Concentrations tested  ranged from
-25-225 mM.
6.4.   IERATOGENICITY
    Pertinent  data  regarding  the teratogenlclty of  furan  could  not  be
located 1n the available literature as dted 1n Appendix  A.
6.5.   OTHER REPRODUCTIVE EFFECTS
    Pertinent data  regarding other reproductive  effects  of furan  could  not
be located In the available literature as cited 1n Appendix  A.
6.6.   SUMHARY
    Dose-related toxic  hepatitis was reported  1n both  sexes  of  F-344  rats
and  B6C3F1  mice when  furan  was administered  by  gavage  for 13  weeks  (SRI,
1982a,b).  The  liver lesions  were considered minimal In low-dose rats  and
did  not  occur  In  the  two  lowest dose  groups   of  male and  female  mice.


0067d                               -17-                             09/25/87

-------
High-dose  male  and  female rats  and high-dose  male mice  had  reduced  body
weight  gains.   Dose-related  Increase  1n liver  weight  was  reported  In  all
treated rats except  low-dose  females  and In male and female mice at  the  two
highest dose levels.
    Pertinent data  regarding  the  cardnogenlclty,  teratogenlclty  or  other
reproductive effects of  furan  could  not  be located  1n the  available  litera-
ture  as  cited  1n  Appendix A.  Furan was  reported  to  be nonmutagenlc  when
tested  In  the  presence and absence  of S-9  1n assays with  Salmonella  typhl-
murlum and Euglena qraclHs (Mortelmans et a!.,  1986; EbMnge et al.,  1979).
Furan was  clastogenlc  to  Chinese  hamster  ovary cells when cultured  1n  the
presence of S-9  (Stlch  et al., 1981).
0067d                               -18-                             10/02/87

-------
                     7.   EXISTING GUIDELINES AND STANDARDS

7.1.   HUMAN

    Pertinent guidelines and  standards,  Including EPA ambient water  and  air

quality criteria, drinking water standards,  FAO/WHO ADIs, EPA or  FDA toler-

ances  for  raw agricultural commodities  or foods,  and  ACGIH, NIOSH  or  OSHA
                 »
occupational exposure  limits  could not be  located  In the available  litera-

ture as  cited  In Appendix A.   U.S.  EPA  (1986c)  has verified a  chronic  oral

RfD  of 0.1  mg/day   for  furan,  based  on  a  NOAEL of  2  mg/kg  from  a  mouse

subchronlc oral  gavage study  (SRI,  1982b).

7.2.   AQUATIC

    Guidelines and  standards  for  the protection of  aquatic organisms  from

the  effects  of   furan  could  not be  located In the  available literature  as

cited 1n Appendix A.
0067d                               -19-                             10/02/87

-------
                              8.   RISK  ASSESSMENT
8.1.   CARCINOGENICITY
    Hlstopathologlcal examination  regarding  the carclnogenldty of  furan  Is
currently  In  progress for  the  2-year  NTP gavage  study using rats  and  mice
(NTP,  1987);   therefore,  lack  of  data  precludes  quantitative  assessment.
                   »              »
However,  sufficient  data are  available  for  derivation of  an  RfD  for  oral
exposure.
8.1.1.   Weight of Evidence.  Since  no data  are currently  available regard-
ing the  cardnogenlclty  of  furan  to humans  or animals, H  Is classified  as
an EPA Group D compound (U.S.  EPA,  1986d).
8.1.2.   Quantitative  Risk  Estimates.    Insufficient  Information  precludes
the  derivation  of  quantitative  risk  estimates for  the cardnogenlclty  of
furan by either oral  or Inhalation exposure.
8.2.   SYSTEMIC TOXICITY
8.2.1.   Inhalation  Exposure.   Pertinent data  regarding  the   toxlclty  of
furan by  the  Inhalation  route  could not  be  located  In  the  available litera-
ture as cited In Appendix A.  RfDs  for  Inhalation  exposure  cannot be derived.
8.2.2.   Oral  Exposures.
    8.2.2.1.   LESS  THAN  LIFETIME  (SUBCHRONIC)  — An   RfD  for  furan  was
previously derived and verified by U.S.  EPA (1986c) from oral exposure  data
reported by SRI  (1982a,b).  The  study  was discussed 1n  Section  6.1.2.1. and
the following risk assessment  was  presented by  U.S.  EPA  (1986c).
    SRI  (1982a,b)  conducted a  13-week  gavage  study  using  groups of  10  male
and female  F-344  rats and  10 female  B6C3F1 mice  treated  5 days/week  with
doses  of 0,  4,  8,  15,  30,  and   60 mg/kg  furan  In corn  oil.   Male mice,
however, were administered with doses  of 0,  2, 4, 8, 15 and  30  mg/kg.   Data
regarding  mortality,   body  weight,   organ  weights,  and  clinical  and
h1stopatholog1cal  signs  of  toxlclty  were  evaluated.   High-dose  male  and

0067d                               -20-                             10/02/87

-------
female rats  and  high-dose male mice  had treatment-related reduced  rates  of
body  weight   gain.    H1stopatholog1cal   examination  In   rats   revealed   a
dose-related  Increased  severity In liver  lesions,  with lesions  observed  at
the  low-dose  level  considered minimal to  mild.   A dose-related  Increase  1n
liver weight  was  also reported  In  all  treated groups  of  males and  all  but
the  low-dose  group  of  female rats.   In mice,  treatment-related  Increases  1n
liver weight  occurred  1n males  at  >15  mg/kg and  1n  females at  >30 mg/kg.
H1stopatholog1cal  evaluation  revealed dose-related  toxic  hepatitis  In  male
mice at doses of >8 mg/kg and 1n female mice at doses of >15 mg/kg.
    The  SRI  (1982a) data  Indicate  that  the  rat  study failed  to define  a
threshold for  toxic  hepatitis,  which was  the critical effect  1n  the target
organ for  the toxlclty of furan. The mouse study  (SRI, 1982b)  Identified  a
threshold for toxic hepatitis of 4  mg/kg,  the highest  dose 1n males at which
lesions  did  not  occur; mild  lesions  of  toxic hepatitis occurred  at  8 mg/kg
\n males.  In  females,  lesions  of  toxic hepatitis  were  reported  at 15 mg/kg
but not 8 mg/kg.  Since  lesions of  toxic  hepatitis  were  present 1n rats at  4
mg/kg, the highest NOAEL  Identified for  both  species was  2 mg/kg In the male
mice.  Since  the  treatment  was  performed 5  days/week,  the 2 mg/kg  dose  1s
transformed to an equivalent  dose of  1.4  mg/kg/day.  Applying an  uncertainty
factor of  100 to the  mouse  NOAEL  of 1.4  mg/kg/day results  In a  subchronlc
oral RfD of  0.01  mg/kg/day,  or  1 mg/day for  a 70 kg human.   The  uncertainty
factor  of  100  was  selected  based  on   a   factor  of  10  to  account  for
Interspedes extrapolation and another factor  of 10  to protect  the unusually
sensitive  Individuals  of  the  population.    The  confidence  In  the  RfD  1s
considered  medium   since the  critical   study  provided  adequate  toxlclty
endpolnts  1n  a well-designed multlspecles  oral  study,  but  data were  not
0067d                               -21-                             10/02/87

-------
available  regarding   the   cardnogenldty,   developmental   or   reproductive
toxIcHy  of  furan.  Availability  of the  data from  the  NTP chronic  gavage
bloassay may change the RfD and the level  of confidence (NTP,  1987).
    8.2.2.2.   CHRONIC EXPOSURES -- No pertinent  data are available  regard-
ing  the  chronic  oral  exposure of  furan  to  animals  or  humans;  however,  a
chronic  oral  RfD  can  be  derived  from  the  subchronlc  RfD  by  applying  an
additional  uncertainty factor  of   10  for  extrapolation  from subchronlc  to
chronic exposure.  Applying an uncertainty factor of  1000 to  the  mouse NOAEL
of  1.4 mg/kg/day  results   In  a  chronic  oral  RfD  of  1  yg/kg/day,  or  0.1
mg/day for  a  70 kg man.   A medium level  of  confidence  1n  the RfD  reflects
the confidence In the key study and the  total  data base for  furan.
0067d                               -22-                             10/02/87

-------
                           9.  REPORTABLE QUANTITIES
 9.1.    BASED  ON  SYSTEMIC TOXICITY
     The effects  of  subchronlc  oral  exposure  to  furan  were  discussed  In
 Section 6.1.2.1.  and data  for derivation of CSs are summarized  1n Table 9-1.
 These  data  Indicate three  types  of toxic effects associated with exposure to
 furan.   Mortality  occurred  In rats  of both  sexes In  the 60  mg/kg group.
 Degenerative,  necrotlc and  hyperplastlc liver  lesions,  assigned an  RV  of
 8,  occurred In male and female rats at  8 mg/kg,  In male  mice at 8 mg/kg and
 In  female  mice  at  15  mg/kg.  Minimal  or  mild  liver  lesions,  assigned  an
 RV   of 6,  occurred  In  male  and  female rats at  4 mg/kg.   CSs are calculated
 for  each of  these  effects  In Table  9-2  using  the  data  that  generate the
 lowest  equivalent  human dose.  The largest  CS, 37.6,  which corresponds to an
 RQ   of   100  pounds  and  1s  associated  with  degenerative,  necrotlc  and
 hyperplastlc  liver lesions In male mice, Is  chosen to  represent the chronic
 toxldty of furan  (Table 9-3).
 9.2.    BASED  ON  CARCINOGENICITY
     Pertinent  data  regarding the carclnogenlcHy of  furan  could not  be
 located 1n  the available  literature as  cited  In Appendix A.   Because hlsto-
 pathology  from a  2-year oral  gavage  study using rats  and mice Is currently
 In  progress,  the  data  are unavailable  (NTP,  1987).  Therefore, Insufficient
.data  preclude  the  derivation  of  carcinogenic potency  factors.   Furan  Is
 assigned  to  EPA  Group D,  not classifiable  as to  carclnogenldty.   Hazard
 ranking based  on carclnogenldty 1s not  possible.
 0067d                               -23-                             10/02/87

-------
                                                                            TABLE  9-1
                                                                 Oral  Toxlclty  Summary  for  Furan
Q.



1
*•
1




O
O
ro
Species/
Strain
Rat/Fischer
344
Rat/Fischer
344
Rat/Fischer
344
Rat/Fischer
344
Rat/Fischer
344
Rat/Fischer
344
Nouse/B6C3Fl
Nouse/B6C3Fl
'Calculated
bTrans formed
Calculated

Sex/
Number
N/10
N/10
N/10
F/10
F/10
F/10
N/10
F/10
Average Body
Weight'
(kg)
0.165
0.296
0.298
0.151
0.183
0.179
0.034
0.025
from weekly group average body
Purity/
Vehicle
>98X/
corn oil .
>98X/
corn oil
>98X/
corn oil
>98X/
corn oil
>98X/
corn oil
>98X/
corn oil
>98X/
corn oil
>98X/
corn oil
weight data
dosage calculated by expanding treatment
by multiplying

Exposure
60 mg/kg.
5 days/week,
13 weeks
8 mg/kg.
5 days/week,
13 weeks
4 mg/kg.
5 days/week,
13 weeks
60 mg/kg.
5 days/week,
13 weeks
8 mg/kg.
5 days/week,
13 weeks
4 mg/kg.
5 days/week.
13 weeks
8 mg/kg.
5 days/week.
13 weeks
15 mg/kg.
5 days/week.
13 weeks
Transformed
Animal Dose0
(mg/kg/day)
42.9
5.7
2.9
42.9
5.7
2.9
5.7
10.7
Equivalent
Human Dosec Response
(mg/kg/day)
5.71 Mortality
0.92 Degenerative, necrotlc.
hyperplastlc lesions In
liver
0.47 Nlld liver lesions
5.54 Mortality
0.79 Degenerative, necrotlc.
hyperplastlc lesions In
liver
0.40 Nlld liver lesions
0.45 Degenerative, necrotlc.
hyperplastlc lesions In
liver
0.76 Degenerative, necrotlc,
hyperplastlc lesions In
liver
Reference
SRI. 19823
SRI, 19823
SRI. 19823
SRI. 19823
SRI. 19823
SRI. 19823
SRI, 1982b
SRI. 1982b
provided by Investigators.
over a 7 -day week.

the animal dosage by the cube root of the ratio of the animal





to human reference body weight (70 kg).




00

-------
o

—J
Q.
                                                   TABLE 9-2


                                        Oral Composite Scores for Furan
Species Animal Dose
(mg/kg/day)
t Rat 42.9
^Mouse 5.7
Rat 2.9
Human MED*
(rag/day)
38.8
3.2
2.8
RVd
3.1
4.7
4.8
Effect RVe CS
Mortality 10 31
Degenerative. 8 37.6
necrotlc,
hyperplastlc
liver lesions
Mild liver 6 28.8
lesions
RQ Reference
100 SRI. 1982a
100 SRI. 1982b
100 SRI. 1982a
  'Calculated by multiplying the equivalent human dose expressed  In mg/kg/day  by 70 kg and applying a factor
   of 10 to expand from subchronlc  to chronic  exposure.
o

\
CO

-------
                                   TABLE  9-3
                                     Furan
           Minimum Effective  Dose  (MED) and Reportable  Quantity  (RQ)


Route:                  oral/gavage
Dose*:                  3.2 mg/day
Effect:                 degenerative, necrotlc, hyperplastlc liver lesions
Reference:              SRI,  1982b
RVd:                    4.7
RVe:                    8
Composite Score:        37.6
RQ:                     100

'Equivalent human dose
0067d                               -26-                             10/02/87

-------
                               10.  REFERENCES

Atkinson, R.   1985.   Kinetics  and mechanisms of  the gas-phase reactions  of
hydroxyl radical with organic compounds  under atmospheric  conditions.   Chem.
Rev.  85: 69-201.

Atkinson, R.. S.M. Aschmann, A.M. Winer  and W.P.L. Carter.   1985.   Rate con-
stants  for  the gas-phase reactions  of NO. radicals  with furan,  thlophene,
and pyrrole  at  295K  and atmospheric  pressure.   Environ.  Sd. Technol.   19:
87-89.

BoubHk, T.,  V.  Fried  and  E.  Hala.   1984.   The  vapor  pressures of  pure
substances:   Selected  values  of   the   temperature  dependence  of  the  vapour
pressures of  some pure  substances  1n  the normal and  low pressure  region.
Vol. 17.  Elsevler Sc1.  Publ.,  Amsterdam, Netherlands.

Call,  D.J.,  L.T.  Brooke,  M.L.  Knuth,  S.H.  Po1r1er  and M.D.  Hoglund.   1985.
F1sh  subchronlc  toxlclty  prediction  model  for  Industrial organic  chemicals
that produce narcosis.  Environ.  Toxlcol. Chem.   4(3):  335-341.

Conkle,   J.P.,  B.J. Camp and B.E. Welch.   1975.   Trace composition of  human
respiratory gas.  Arch.  Environ.  Health.   30:  290-295.

Ounlop,   A.P.    1966.   Furfural.   In.:  K1rk-0thmer Encyclopedia  of  Chemical
Technology,   2nd  ed.,  Vol.   10, A.  Standen, Ed.   John  Wiley  and Sons,  Inc.,
New York.  p. 247-248.
0067d                               -27-                             10/02/87

-------
EbMnge,  L.,  N.  LahHova  and  S.  Trubaclk.    1979.   Determination  of  the
mutagenldty  and  potential  carclnogenldty   of   chemical   substances  with
microorganisms.   Acta Fac. Rerum Nat. Univ. Comenlanae, Form. Prot. Nat.  5:
131-147.

Egle, J.L., Or.  and B.J. Gochberg.  1979.  Respiratory  retention and acute
toxlclty of furan.   Am.  Ind. Hyg.  Assoc.  J.  40(4): 310-314.

Elsenrelch, S.J.,  B.B.  Looney  and J.D.  Thornton.   1981.   Airborne organic
contaminants of  the Great Lakes  ecosystem.   Environ.  Sc1.  Technol.  15(1):
30-38.

Elder,  V.A.,  B.L.  Proctor  and  R.A.  HHes.   1981.   Organic  compounds found
near  dump  sites In  Niagara Falls,  New  York.  Environ. Scl.  Technol.   15:
1237-1243.

Gamma 1,  L.N., R.A'.  Wiley,  G. Tralger,  H.M.   Haschek and S.  Baraban.   1984.
Toxldty distribution relationships  among  3-alkylfurans 1n  the  mouse lung.
Toxicology.  30(2):  177-184.

Great Lakes Water Quality Board.  1983.  An Inventory of chemical substances
Identified  In the  Great  Lakes  Ecosystem.  Vol.  1 - Summary;  Report  to the
Great Lakes Water Quality Board.   Windsor,  Ontario, Canada,  p. 195.

Hampton, C.V.,  W.R.  Plerson, T.H. Harvey, N.S.  Updegrove and  R.S. Marano.
1982.   Hydrocarbon  gases  emitted  from  vehicles on the  road.   I. A qualita-
tive  gas  chromatography/mass spectrometry survey.  Environ.  Sc1.  Technol.
16: 287-298.

0067d                              -28-                             10/02/87

-------
Hansch,  C.  and  A.J.  Leo.   1985.   Medchem Project  Issue no.  26.   Pomona
College, Claremont,  CA.

Hawley,  G.G.    1981.   The  Condensed  Chemical  Dictionary,  10th  ed.   Van
Nlostrand Relnhold Co.,  New York.   p.  483.

Isldorov,  V.A.,  I.G.  Zenkevlch   and  B.V.  loffe.   1985.   Volatile organic
compounds In the atmosphere of  forests.  Atmos.  Environ.   19:  1-8.

Klnlln. T.E..  R.  Muralldhara.  A.O.  PUtet,  A. Sanderson  and J.P. Walradt.
1972.  Volatile components  1n  roasted filberts.  J.  Agrlc.  Food Chem.   20:
1021.

Klelndlenst, I.E.,  P.B.  Shepson,  E.O.  Edney,  L.D.  Claxton and  L.T CupHt.
1986.  Wood  smoke:  Measurement of  the  mutagenlc activities  of  Us gas  and
partlculate-phase  photooxldatlon   products.    Environ.   Scl.  Technol.    20:
493-501.

Krotoszynskl,   B.K.,  G.M.  Bruneau  and H.J. O'Neill.   1979.   Measurement of
chemical Inhalation  exposure  1n   urban  population  In the  presence of endo-
genous effluents.   J. Anal.  Toxlcol.   3: 225-234.

Lee,  J.H.  and  I.N.   Tang.   1982.   Absolute rate constants for  the hydroxyl
radical reactions with ethane,  furan, and thlophene at room temperature.  J.
Chem. Phys.  77(9):  4459-4463.
0067d                               -29-                              10/02/87

-------
Lyman, W.J.,  W.F.  Reehl  and  D.H. Rosenblatt.   1982.   Handbook of  Chemical
Property Estimation Methods.  McGraw  H111  Book Co., New York.   p.  4-9,  5-5,
7-4, 15-13, 15-21,  15-27.

Masuda, Y., N.  Nakayama,  A.  Yamaguchl and M.  Hurohashl.   1984.  The effects
of  d1ethyld1th1ocarbamate  and carbon  dlsulflde  on acute  nephrotoxlclty  In-
duced by furan,  bromobenzene  and  cephalorldlne In mice.   Jpn.  J.  Pharmacol.
34(2): 221-229.

HcKlllIp,   W.J.  and E.  Sherman.   1980.  Furan derivatives,  in: K1rk-0thmer
Encyclopedia  of  Chemical  Technology,  3rd ed.,  Vol.  11,  M.  Grayson and  D.
Eckroth,  Ed.  John  Wiley and Sons, Inc.,  New  York.   p.  516-520.

Mortelmans, K.,  S. Haworth,  T.  Lawlor,  W. Speck,  B.  Talner  and E.  Zelger.
1986.  Salmonella  mutagenldty  tests: II. Results from the  testing of  270
chemicals.   Environ.  Mutagen.   8:  1-119.

NIOSH  (National  Institute  for   Occupational  Safety   and Health).   1984.
Current Awareness  File.   Registry  of Toxic   Effects  of Chemical  Substances
(RTECS).   NIOSH, Cincinnati,  OH.

NTP  (National  Toxicology  Program).   1987.  Management Status Report.   Dated
01/09/87.

PelUzzarl, E.D., N.P. Castillo,  S. H1ll1s, 0. Smith and J.T. Bursey.   1979.
Identification  of  organic components  In  aqueous  effluents  from  energy-
related processes.   In:  ASTM Spec.  Tech.  Publ.; STP 686:  256-74.


0067d                               -30-                              10/02/87

-------
Pelllzzarl, E.O., T.D.  Hartwell,  B.S.H.  Harris,  R.D. Waddell, O.A. WhHaker
and  M.D.  EMckson.    1982.   Purgeable  organic  compounds  In  mother's milk.
Bull. Environ.  Contam. Toxlcol.   28:  322-328.

R1dd1ck, J.A.,  H.B.  Bunger and T.K. Sakano.  1986.   Organic solvents:  Physi-
cal  properties  and  methods  of  purification.   JJK  Techniques of  Chemistry,
Vol. 2, 4th ed.   W1ley-Intersdence,  New York, NY.   p.  1325.

Sakuma, H.,  H.  Kugama  and  S.  Sugawara.   1975.   Studies  on  cellulose ciga-
rette  smoke.   I. Introducing main stream  smoke  Into  a  gas  chromatograph.
Nippon Sembal Kosha  Chuo Kenkyusho Kenkyu Hokoku.   117:  47-54.

Sax,  N.I.,   Ed.   1984.   Dangerous  Properties  of   Industrial  Metals.   Van
Nostrand Relnhold Co., New York.

SRI  (Southern  Research Institute).   1982a.   Subchronlc  toxlclty  report on
furan  (C56202)  In F1scher-344 rats.   Prepared  for National Toxldty  Program
under Contract  No. N01-CP-95651-01.  Bethesda, HD.

SRI  (Southern  Research Institute).   1982b.   Subchronlc  toxlclty  report on
furan  (C56202)  In B6C3F1 mice.  Prepared  for National Toxlclty Program under
Contract No. N01-CP-95651-01.  Bethesda,  HD.

SRI  (Stanford   Research  Institute).    1986.   1986  Directory   of Chemical
Producers:  United States of America SRI  International,  Menlo Park,  CA.
0067d                               -31-                             10/02/87

-------
Stasenkova,  K.P.  and  T.A.  Kochetkova.   1968.   Comparative  evaluation  of
toxlclty  In  a  series  of   furan  compounds.   Tokslkol.  Nov.  Prom.  Khlm.
Veshchestv, No. 10, 35-44.

Stlch, H.F., M.P.  Rosin,  C.H.  Wu and W.D.  Powrle.   1981.   ClastogenlcHy of
furans found In food.  Cancer Lett.   13(2): 89-95.

Swann, R.L., D.A.  Laskowskl, P.J. McCall,  K.  Vander  Kuy and H.J. Dlshburger.
1983.  A  rapid  method for   the  estimation of  the  environmental  parameters
octanol/water  partition coefficient, soil  sorptlon constant,  water  to  air
ratio and water solubility.   Res. Rev.  85: 17-28.

U.S.  EPA.   1980.   Guidelines  and  Methodology Used In  the Preparation  of
Health  Effect   Assessment Chapters  of  the  Consent Decree Water  Criteria
Documents.   Federal Register.  45(231):  79347-79357.

U.S.  EPA.   1984.    Methodology  and   Guidelines  for   Reportable  Quantity
Determinations   Based  on Chronic Toxlclty  Data.  Prepared  by  the Office  of
Health and  Environmental Assessment,  Environmental  Criteria and  Assessment
Office, Cincinnati, OH  for the Office of Solid  Waste and Emergency Response,
Washington, DC.

U.S.  EPA.   1986a.   Methodology  for  Evaluating Potential  Carclnogenlclty  1n
Support of  Reportable Quantity Adjustments Pursuant to CERCLA  Section  102.
Prepared by  the Office of   Health and  Environmental Assessment,  Carcinogen
Assessment  Group,  for  the   Office  of  Solid  Waste  and Emergency  Response,
Washington, DC.

0067d                               -32-                             10/02/87

-------
 U.S.  EPA.  1986b.   OHMTAOS  (011  and Hazardous Material Technical Assistance
 Data  Systems).   Data base.   On-Hne.

 U.S.  EPA.   1986c.   Integrated  Risk  Information  System  (IRIS).  Reference
 dose  (RfD) for oral  exposure  for  furan.   Online (Revised; verification  date
 11/16/86).  Office  of  Health and  Environmental  Assessment,   Environmental
 Criteria and Assessment  Office, Cincinnati,  OH.

 U.S.  EPA.  1986d.   Guidelines  for  Carcinogen  Risk  Assessment.   Federal
 Register.   51(185):  33992-34003.

 U.S.  EPA.  1987.   Graphical  Exposure  Modeling  System  (GEMS).    Fate of
 atmospheric  pollutants   (FAP).    Office  of  Toxic  Substances,  U.S.   EPA,
 Washington, DC.

 USITC  (U.S.   International  Trade   Commission).   1986.   Synthetic  Organic
 Chemicals, United  States  Production  and  Sales,   1985.   USITC  Publ.  1745,
 Washington, DC.

 Valvanl,  S.C.,  S.H.  Yalkowsky  and  T.J.   Roseman.   1981.    Solubility  and
 partitioning.   IV.  Aqueous solubility  and octanol-water  partition  coeffi-
 cients  of  liquid  nonelectrolytes.  J.  Pharm. Scl.  70:  502-507.

_Ve1th,  G.D.,  D.J. Call  and L.T. Brooke.  1983.  Structure-toxlclty relation-
 ships  for the   fathead  minnow,   Plmephales  promelas:  Narcotic Industrial
 chemicals. Can.  J.  F1sh.  Aquat.  Sc1.  40(6):  743-748.
 0067d                               -33-                             10/02/87

-------
Verschueren, K.  1983.  Handbook of Environmental Data on  Organic  Chemicals,
2nd ed.  Van Nostrand Relnhold Co.,  New York,  NY.

Wiley,  R.A.,  G.J.  Tralger,  S.  Baraban  and L.M. Gammal.   1984.   Toxldty-
d1str1but1on relationships  among  3-alkylfurans  In  mouse  liver  and  kidney.
Toxlcol. Appl.  Pharmacol.   74(1):  1-9.

Wlndholz, M.,  Ed.   1983.   The  Herck  Index.  An  Encyclopedia of  Chemicals,
Drugs and Blologlcals, 10th ed.  Merck  and  Co.,  Inc.,  Rahway,  NJ.   p.  613.
0067d                               -34-                             10/02/87

-------
Stasenkova,  K.P.  and  T.A.  Kochetkova.   1968.   Comparative  evaluation  of
toxlclty  In  a  series  of   furan   compounds.   Tokslkol.  Nov.  Prom.  Kh1m.
Veshchestv, No. 10, 35-44.

Stlch, H.F.,  M.P.  Rosin,  C.H.  Wu and W.D.  Powrle.   1981.   Clastogenldty of
furans found  1n food.  Cancer Lett.  13(2): 89-95.

Swann, R.L.,  D.A.  Laskowskl, P.J. McCall,  K.  Vander  Kuy and H.J. Dlshburger.
1983.  A  rapid  method for   the  estimation of  the  environmental  parameters
octanol/water  partition  coefficient, soil  sorptlon constant,  water  to  air
ratio and water solubility.   Res. Rev.   85: 17-28.

U.S.  EPA.   1980.   Guidelines  and  Methodology Used 1n  the Preparation  of
Health  Effect  Assessment  Chapters  of  the  Consent Decree Water  Criteria
Documents.  Federal Register.  45(231):  49347-49357.

U.S.  EPA.    1984.   Methodology  and   Guidelines  for   Reportable  Quantity
Determinations  Based on  Chronic Toxlclty  Data.  Prepared  by  the Office  of
Health and  Environmental Assessment,  Environmental  Criteria and  Assessment
Office, Cincinnati, OH for the Office of Solid  Haste and Emergency Response,
Washington, DC.

U.S.  EPA.   1986a.   Methodology  for  Evaluating Potential  Carc1nogen1c1ty  In
Support of  Reportable  Quantity Adjustments Pursuant to CERCLA  Section  102.
Prepared  by  the Office  of   Health  and  Environmental Assessment,  Carcinogen
Assessment  Group,  for  the   Office  of   Solid  Waste  and Emergency  Response,
Washington, DC.

0067d                               -32-                             10/02/87

-------
                                  APPENDIX A

                              LITERATURE  SEARCHED



    This  HEED  Is  based  on  data  Identified  by  computerized  literature

searches of the following:
         TSCATS
         CASR online (U.S. EPA Chemical Activities Status Report)
         TOXLINE
         TOXBACK 76
         TOXBACK 65
         RTECS
         OHM TADS
         STORET
         SRC Environmental Fate Data Bases
         SANSS
         AQUIRE
         TSCAPP
         NTIS
         Federal Register


These searches were conducted  In February,  1987.   In  addition,  hand searches

were made of  Chemical  Abstracts  (Collective Indices 5-9), and  the  following

secondary sources should be reviewed:


    ACGIH (American  Conference of Governmental  Industrial  Hyglenlsts).
    1986.   Documentation  of  the Threshold  Limit Values  and  Biological
    Exposure Indices, 5th ed.  Cincinnati, OH.

    ACGIH (American  Conference of Governmental  Industrial  Hyglenlsts).
    1986-1987.  TLVs: Threshold Limit  Values for  Chemical Substances 1n
    the  Work  Environment  adopted  by  ACGIH with  Intended Changes  for
    1986-1987.  Cincinnati, OH.  Ill  p.

    Clayton,  G.D.   and   F.E.  Clayton,  Ed.   1981.   Patty's  Industrial
    Hygiene and Toxicology,  3rd  rev.  ed., Vol.  2A.   John  Wiley  and
    Sons, NY.   2878 p.

    Clayton,  G.D.   and   F.E.  Clayton,  Ed.   1981.   Patty's  Industrial
    Hygiene and Toxicology,  3rd  rev.  ed., Vol.  28.   John  Wiley  and
    Sons, NY.   p. 2879-3816.

    Clayton,  G.D.   and   F.E.  Clayton,  Ed.   1982.   Patty's  Industrial
    Hygiene and Toxicology,  3rd  rev.  ed., Vol.  2C.   John  Wiley  and
    Sons, NY.   p. 3817-5112.
0067d                               -35-                             10/02/87

-------
    Grayson,  M.  and 0.  Eckroth,  Ed.   1978-1984.   K1rk-0thmer  Encyclo-
    pedia of  Chemical Technology, 3rd  ed.   John  Wiley and Sons, NY.  23
    Volumes.

    Hamilton, A. and H.L.  Hardy.  1974.   Industrial  Toxicology, 3rd ed.
    Publishing Sciences Group, Inc., Littleton, MA.  575 p.

    IARC  (International  Agency  for  Research  on  Cancer).   IARC  Mono-
    graphs  on  the  Evaluation  of  Carcinogenic   Risk  of  Chemicals  to
    Humans.  MHO, IARC, Lyons, France.

    Jaber,  H.M.,  W.R.  Mabey,  A.T.   Lieu,  T.W.  Chou  and  H.L.  Johnson.
    1984.   Data  acquisition   for   environmental   transport   and  fate
    screening for compounds  of Interest  to  the  Office of Solid  Waste.
    SRI   International,  Menlo   Park,  CA.    EPA   600/6-84-010.    NTIS
    PB84-243906.

    NTP  (National Toxicology  Program).  1986.   Toxicology Research and
    Testing   Program.   Chemicals   on   Standard   Protocol.   Management
    Status.

    Ouellette,  R.P. and   J.A.  King.   1977.   Chemical  Week  Pesticide
    Register.  McGraw-Hill  Book Co., NY.

    Sax,  I.N.   1984.  Dangerous Properties  of  Industrial  Materials, 6th
    ed.  Van Nostrand Relnhold Co.,  NY.

    SRI  (Stanford  Research  Institute).   1986.   Directory of  Chemical
    Producers.  Menlo Park, CA.

    U.S.  EPA.   1986.   Report  on  Status  Report  1n  the Special  Review
    Program,  Registration   Standards  Program and  the  Data  Call  In
    Programs.   Registration  Standards and  the  Data  Call  1n  Programs.
    Office of Pesticide Programs,  Washington,  DC.

    U.S.  EPA.   1985.  CSB  Existing  Chemical Assessment  Tracking System.
    Name  and  CAS Number Ordered  Indexes.   Office of Toxic  Substances,
    Washington,  DC.

    USITC  (U.S.  International   Trade  Commission).    1985.    Synthetic
    Organic  Chemicals.   U.S.  Production  and   Sales,  1984, USITC  Publ.
    1422, Washington.  DC.

    Verschueren, K.  1983.  Handbook  of  Environmental  Data  on Organic
    Chemicals, 2nd ed.   Van Nostrand Relnhold  Co.,  NY.

    Wlndholz, M., Ed.  1983.  The Merck Index, 10th  ed.   Merck  and Co.,
    Inc.. Rahway, NJ.

    Worthing, C.R.  and  S.B. Walker,  Ed.   1983.   The Pesticide Manual.
    British Crop Protection Council.  695  p.
0067d                               -36-                             10/02/87

-------
_    In  addition, approximately  30 compendia  of  aquatic  toxldty  data were

 reviewed,  Including the following:


     Battelle's  Columbus  Laboratories.   1971.   Water  Quality  Criteria
     Data   Book.   Volume  3.  Effects  of  Chemicals  on  Aquatic  Life.
     Selected  Data from the  Literature  through 1968.   Prepared  for the
     U.S.  EPA  under Contract No. 68-01-0007.  Washington, DC.

     Johnson,  W.W. and  H.T.  Flnley.   1980.  Handbook  of Acute Toxldty
     of  Chemicals  to  F1sh  and  Aquatic   Invertebrates.   Summaries  of
     Toxldty  Tests Conducted  at  Columbia National  Fisheries  Research
     Laboratory.   1965-1978.   U.S. Dept.  Interior,  F1sh   and  Wildlife
     Serv.  Res. Publ. 137, Washington, DC.

     McKee,  J.E.  and  H.W.  Wolf.  1963.  Water  Quality Criteria,  2nd ed.
     Prepared  for  the  Resources  Agency  of  California,  State  Water
     Quality Control Board.  Publ.  No. 3-A.

     Plmental, D.   1971.   Ecological  Effects  of Pesticides on Non-Target
     Species.  Prepared for the U.S. EPA, Washington, DC.  PB-269605.

     Schneider, B.A.   1979.   Toxicology  Handbook.   Mammalian and Aquatic
     Data.   Book  1: Toxicology  Data.   Office  of Pesticide Programs, U.S.
     EPA,  Washington, DC.  EPA 540/9-79-003.  NTIS PB 80-196876.
 0067d                               -37-                             10/02/87

-------
                                                APPENDIX B



                                          Summary  Table  for  Furan
Species
Inhalation Exposure
Subchronlc ID
Chronic ID
Carclnogenlclty ID
l^ Oral Exposure
CO
Subchronlc mice
Chronic mice
Carclnogenlclty ID
REPORTABLE QUANTITIES
_, Based on Chronic Toxldty:
o
\
S Based on Carclnogenlclty:
on
Exposure

ID
ID
ID
2 mg/kg.
5 days/week,
13 weeks
2 mg/kg,
5 days /week,
13 weeks
ID

too
ID
Effect

ID
ID
ID
toxic
hepatitis
toxic
hepatitis
ID


RfD or q-j* Reference

ID ID
ID ID
ID ID
1 mg/day SRI, 1982b
0.1 mg/day SRI. 1982b
ID ID

SRI. 1982b
ID = Insufficient  data

-------